Fresenius SE
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
Guided Tour
|
German
WHO WE ARE
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Environment
History
Frequently Asked Questions
Contacts
INVESTOR RELATIONS
The Fresenius Shares
Credit Relations
News
Financial Reports
Presentations
Corporate Governance
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
PRESS
Press Releases
Photo Service
Audio/Video Service
TV Service
Calendar
Facts and Figures
Contacts
HEALTHCARE
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
All Segments
CAREER
Why Fresenius?
Who we are looking for
Job Market
Online application
Career Fairs
Personnel in Numbers
Around our Plants
Contacts
SEARCH
The Fresenius Shares
Credit Relations
News
Investor News
2010
2009
2008
2007
2006
2005
2004
2003
Ad hoc News
Financial Reports
Presentations
Corporate Governance
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Share Price
Next Event
04.05.2010
Report on Q1 2010
>>>
Further events
>>>
Annual Report 2008
Please click here to view our Annual Report 2008
>>>
Please click here to view our Online Annual Report 2008
>>>
Awards 2009
Award for 2008 Annual Report
Best Borrower-High Yield Award 2009
Further information
>>>
To view PDF-files you need Adobe Reader. You can download this software free of charge.
Investor News 2003
04.11.2003
1st nine months 2003
(for tables please see pdf-file)
Text as PDF-File
23.09.2003
Phase I/II study completed successfully: New antibody to treat ovarian cancer patients with symptomatic ascites (fluid accumulation in the abdominal cavity) shown to be well tolerated
Text as PDF-File
05.08.2003
1st half 2003
(for tables please see pdf-file)
Text as PDF-File
07.05.2003
1st quarter 2003
(for tables please see pdf-file)
Text as PDF-File
07.03.2003
Fresenius announces change in chairmanship of Managing Board
25.02.2003
2002 Financial year
(for tables please see pdf-file)
Text as PDF-File
Home
>
Investor Relations
>
News
>
Investor News
>
2003